Market Cap 2.37B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 7.03
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.55
Volume 8,519,399
Avg Vol 4,400,160
Day's Range N/A - N/A
Shares Out 254.16M
Stochastic %K 84%
Beta 0.57
Analysts Strong Sell
Price Target $21.30

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
YourGraceIsEnough
YourGraceIsEnough Jun. 25 at 2:57 AM
$BCRX Congrats on a great day friends! 🌸🌻
1 · Reply
mikesterz7
mikesterz7 Jun. 25 at 2:42 AM
$BCRX 🔥🔥🔥
0 · Reply
LilBigWheel
LilBigWheel Jun. 25 at 2:41 AM
$BCRX does this company have a product that sells on the market ?… a pharmaceutical product on the market?
2 · Reply
PatriciaPaxton
PatriciaPaxton Jun. 25 at 2:18 AM
$GOAI Eva Live Targets Cybersecurity Aggressively, Standing Up an Internal Task Force to Meet AI Industry Needs https://www.globenewswire.com/news-release/2026/06/22/3315451/0/en/eva-live-targets-cybersecurity-aggressively-standing-up-an-internal-task-force-to-meet-ai-industry-needs.html $QCOM $BCRX $SLS
0 · Reply
Fergus20
Fergus20 Jun. 25 at 2:17 AM
$BCRX wow overnight buys!!!!!
0 · Reply
Money_Mane
Money_Mane Jun. 25 at 2:15 AM
$BCRX Hb this massive random volume candle. Explain this to me pls
2 · Reply
topstockalerts
topstockalerts Jun. 25 at 2:15 AM
$BCRX buyers appear to be in full control right now
0 · Reply
Fergus20
Fergus20 Jun. 25 at 2:12 AM
$BCRX I am King Fergus.
2 · Reply
drose0527
drose0527 Jun. 25 at 2:04 AM
$BCRX I think tomorrow we will push higher in the morning test cup rim at 10.32 than sell off the majority of the day as we have had 3 straight day of gains and in accordance to last run we are at a point where it has to catch its breath. So I wouldn’t look for much positive out of tomorrow’s trade. I can see us pushing towards 9.70 on the day and closing around shelf breakout probably in the 9.85-9.90 range.
1 · Reply
TrustButVerifi
TrustButVerifi Jun. 25 at 2:03 AM
0 · Reply
Latest News on BCRX
BioCryst to present new Orladeyo data at EAACI

2026-06-12T11:15:09.000Z - 12 days ago

BioCryst to present new Orladeyo data at EAACI


BioCryst price target raised to $28 from $25 at Citizens

2026-05-07T11:43:06.000Z - 6 weeks ago

BioCryst price target raised to $28 from $25 at Citizens


BioCryst reports Q1 EPS ($2.98), consensus 11c

2026-05-07T06:49:24.000Z - 6 weeks ago

BioCryst reports Q1 EPS ($2.98), consensus 11c


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 7 weeks ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 2 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 2 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst price target raised to $14 from $13 at RBC Capital

2026-04-07T15:13:58.000Z - 2 months ago

BioCryst price target raised to $14 from $13 at RBC Capital


BioCryst reports inducement grants under Nasdaq listing rule

2026-03-04T12:08:31.000Z - 4 months ago

BioCryst reports inducement grants under Nasdaq listing rule


BioCryst price target raised to $22 from $21 at Wedbush

2026-03-02T13:53:06.000Z - 4 months ago

BioCryst price target raised to $22 from $21 at Wedbush


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst reports Q4 EPS $1.12 vs (13c) last year

2026-02-26T12:19:23.000Z - 4 months ago

BioCryst reports Q4 EPS $1.12 vs (13c) last year


BioCryst resumed with an Outperform at Evercore ISI

2026-02-18T13:16:21.000Z - 4 months ago

BioCryst resumed with an Outperform at Evercore ISI


BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 4 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst completes acquisition of Astria Therapeutics

2026-01-23T14:05:15.000Z - 5 months ago

BioCryst completes acquisition of Astria Therapeutics

ATXS


BioCryst reports inducement grants under Nasdaq listing rule

2026-01-06T12:20:40.000Z - 6 months ago

BioCryst reports inducement grants under Nasdaq listing rule


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 9 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 9 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 11 months ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 11 months ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 1 year ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2024


BioCryst Pharmaceuticals Annual report: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Annual report: Q4 2024


BioCryst Pharmaceuticals Earnings release: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q4 2024


BioCryst Pharmaceuticals Slides: Q4 2024

Feb 24, 2025, 8:30 AM EST - 1 year ago

BioCryst Pharmaceuticals Slides: Q4 2024


BioCryst Launches ORLADEYO® (berotralstat) in Portugal

Feb 12, 2025, 7:00 AM EST - 1 year ago

BioCryst Launches ORLADEYO® (berotralstat) in Portugal


YourGraceIsEnough
YourGraceIsEnough Jun. 25 at 2:57 AM
$BCRX Congrats on a great day friends! 🌸🌻
1 · Reply
mikesterz7
mikesterz7 Jun. 25 at 2:42 AM
$BCRX 🔥🔥🔥
0 · Reply
LilBigWheel
LilBigWheel Jun. 25 at 2:41 AM
$BCRX does this company have a product that sells on the market ?… a pharmaceutical product on the market?
2 · Reply
PatriciaPaxton
PatriciaPaxton Jun. 25 at 2:18 AM
$GOAI Eva Live Targets Cybersecurity Aggressively, Standing Up an Internal Task Force to Meet AI Industry Needs https://www.globenewswire.com/news-release/2026/06/22/3315451/0/en/eva-live-targets-cybersecurity-aggressively-standing-up-an-internal-task-force-to-meet-ai-industry-needs.html $QCOM $BCRX $SLS
0 · Reply
Fergus20
Fergus20 Jun. 25 at 2:17 AM
$BCRX wow overnight buys!!!!!
0 · Reply
Money_Mane
Money_Mane Jun. 25 at 2:15 AM
$BCRX Hb this massive random volume candle. Explain this to me pls
2 · Reply
topstockalerts
topstockalerts Jun. 25 at 2:15 AM
$BCRX buyers appear to be in full control right now
0 · Reply
Fergus20
Fergus20 Jun. 25 at 2:12 AM
$BCRX I am King Fergus.
2 · Reply
drose0527
drose0527 Jun. 25 at 2:04 AM
$BCRX I think tomorrow we will push higher in the morning test cup rim at 10.32 than sell off the majority of the day as we have had 3 straight day of gains and in accordance to last run we are at a point where it has to catch its breath. So I wouldn’t look for much positive out of tomorrow’s trade. I can see us pushing towards 9.70 on the day and closing around shelf breakout probably in the 9.85-9.90 range.
1 · Reply
TrustButVerifi
TrustButVerifi Jun. 25 at 2:03 AM
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 25 at 1:53 AM
Treasure Thursday Watchlist Trend Multi ​ $SLS $ABSI $BCRX $VKTX $FCEL
0 · Reply
5timechamp
5timechamp Jun. 25 at 1:34 AM
$BCRX "My only concern is that i have no concerns"
1 · Reply
smnorgy
smnorgy Jun. 25 at 1:29 AM
$BCRX Fergy deserves most credit for this reality
0 · Reply
ChillPill1972
ChillPill1972 Jun. 25 at 12:13 AM
$BCRX .32 from 52 week high.
0 · Reply
2YrsEarly
2YrsEarly Jun. 24 at 11:27 PM
$BCRX Million dollar question…. Is this a real move or just another manipulated spike for the big boys to increase premium and sell covered calls once again…. Time will tell!
2 · Reply
Fergus20
Fergus20 Jun. 24 at 11:05 PM
$BCRX 12 days to cover looks mighty nice
0 · Reply
rickdplumr
rickdplumr Jun. 24 at 11:01 PM
0 · Reply
Jedi01
Jedi01 Jun. 24 at 10:55 PM
$BCRX what’s going on here ?
0 · Reply
Fergus20
Fergus20 Jun. 24 at 10:50 PM
$BCRX when do the shorts cover?
1 · Reply
Fergus20
Fergus20 Jun. 24 at 10:19 PM
$BCRX the one week chart might be the nicest looking thing I’ve ever seen
1 · Reply
Stash_Cash
Stash_Cash Jun. 24 at 9:58 PM
$BCRX sold July $11 calls on 1/3 of my holdings, only $0.25 per share. That’s all I will sell for now.
2 · Reply
2YrsEarly
2YrsEarly Jun. 24 at 9:55 PM
$BCRX I wonder if Mr. FOMO that bought at $13 in the overnight session a few months ago will be back for more tonight… 😂
1 · Reply